Plus Therapeutics Regains Compliance with Nasdaq Minimal Bid Worth Requirement
HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV)…
Jena Acquisition Company II Declares Non-Compliance with Phase 802.01B of the NYSE Indexed Corporate Handbook which Calls for the Corporate to Handle a Minimal of 300 Public Stockholders
LAS VEGAS, NEVADA., April 03, 2026 (GLOBE NEWSWIRE) -- Jena Acquisition Company…
GCL Pronounces Receipt of Nasdaq Deficiency Realize Relating to Minimal Bid Value Requirement
SINGAPORE, March 23, 2026 (GLOBE NEWSWIRE) -- GCL International Holdings Ltd (Nasdaq:…
